Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Remote-Control Mechano-Genetics and Epigenetics for Live Cell Manipulation
Relationship between DNA damage detection and signaling
Interaction of uPA/R and Integrins in Oral Cancer
Identifying Female Athletes at High Risk for Acl Injury
Marc Predoctoral Fellowship
Recently added grants:
The role of the androgen receptor in insulin secretion
Development of Near Infrared Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI Cancers
Tumor targeted engineered stem cells for treatment of lung cancer
Interleukin-33 as an immune therapy for stroke
ATP-Citrate Lyase As A Novel Metabolic Target for Osteoarthritis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67190-2-0-1
Application #
7574870
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Albert Einstein College of Medicine
$396,788
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Little, Jane /
$471,185
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant